Evidence map›Paper›PMID 31266232›Full record

ArticleCells2019

The Zinc Transporter Zip7 Is Downregulated in Skeletal Muscle of Insulin-Resistant Cells and in Mice Fed a High-Fat Diet.

Shaghayegh Norouzi, John Adulcikas, Darren C Henstridge, Sabrina Sonda, Sukhwinder Singh Sohal, Stephen Myers

Open access · goldAbstract read
In one paragraph

Article in Cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Zinc homeostasis and redox alterations in obesity.Frontiers in endocrinology · 2023
    Review
  12. Article
  13. Article
  14. Zinc.Advances in food and nutrition research · 2021
    Review
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Shaghayegh NorouziCollege of Health and Medicine, School of Health Sciences, University of Tasmania, Hobart, Tasmania 7005, Australia.
John AdulcikasCollege of Health and Medicine, School of Health Sciences, University of Tasmania, Hobart, Tasmania 7005, Australia.
Darren C HenstridgeCollege of Health and Medicine, School of Health Sciences, University of Tasmania, Hobart, Tasmania 7005, Australia.ORCID 0000-0003-4988-767X
Sabrina SondaCollege of Health and Medicine, School of Health Sciences, University of Tasmania, Hobart, Tasmania 7005, Australia.
Sukhwinder Singh SohalCollege of Health and Medicine, School of Health Sciences, University of Tasmania, Hobart, Tasmania 7005, Australia.
Stephen MyersCollege of Health and Medicine, School of Health Sciences, University of Tasmania, Hobart, Tasmania 7005, Australia. stephen.myers@utas.edu.au.ORCID 0000-0003-4793-3820
University of Tasmania · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe zinc transporter Zip7 modulates zinc flux and controls cell signaling molecules associated with glucose metabolism in skeletal muscle. The present study evaluated the role of Zip7 in cell signaling pathways involved in insulin-resistant skeletal muscle and mice fed a high-fat diet.

methodsInsulin-resistant skeletal muscle cells were prepared by treatment with an inhibitor of the insulin receptor, HNMPA-(AM)3 or palmitate, and Zip7 was analyzed along with pAkt, pTyrosine and Glut4. Similarly, mice fed normal chow (NC) or a high-fat diet (HFD) were also analyzed for protein expression of Glut4 and Zip7. An overexpression system for Zip7 was utilized to determine the action of this zinc transporter on several genes implicated in insulin signaling and glucose control.

resultsWe identified that Zip7 is upregulated by glucose in normal skeletal muscle cells and downregulated in insulin-resistant skeletal muscle. We also observed (as expected) a decrease in pAkt and Glut4 in the insulin-resistant skeletal muscle cells. The overexpression of Zip7 in skeletal muscle cells led to the modulation of key genes involved in the insulin signaling axis and glucose metabolism including

conclusionsThese data suggest that Zip7 plays a role in skeletal muscle insulin signaling and is downregulated in an insulin-resistant, and HFD state. Understanding the molecular mechanisms of Zip7 action will provide novel opportunities to target this transporter therapeutically for the treatment of insulin resistance and type 2 diabetes.

Indexed as

Insulin ResistanceAnimalsCation Transport ProteinsCell LineDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Diet, High-FatDown-RegulationGlucoseGlucose Transporter Type 4InsulinMiceMuscle Fibers, SkeletalSignal TransductionCation Transport ProteinsGlucoseGlucose Transporter Type 4InsulinSlc2a4 protein, mouseSlc39a7 protein, mousehigh-fat dietinsulin signaling pathwayskeletal musclezinczinc transporterZip7

Identifiers

PMID31266232
PMCPMC6678147
OpenAlexW2955822777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.